Trump's FDA nominee tepidly backs role for vaccine advisers in guarded Senate appearance
Martin Makary, President Donald Trump's nominee to run the U.S. FDA, told lawmakers on Thursday he would convene a committee of vaccine advisers but said he would reevaluate which scientific issues require their input.
Trump nominee to head up FDA made no commitments on abortion pill access
WASHINGTON — President Donald Trump’s nominee to lead the Food and Drug Administration refused to commit to keeping access to medication abortion as it is now, or changing prescribing guidelines, in response to questions from both Democrats and Republicans during his confirmation hearing Thursday.
With a U.S. green light for its encapsulated cell therapy technology in the bag, privately held biotech Neurotech ...
Medical device maker Dexcom said it has received a warning letter from the U.S. Food and Drug Administration following ...
One of the most highly anticipated FDA decisions this month is for Alnylam Pharmaceuticals, which is seeking to expand the ...
In particular, AI could assist FDA staff to review drug and device applications, he told senators on the Health, Education, ...
Dr. Marty Makary is largely sidestepping Senate questions about his plans to lead the Food and Drug Administration ...
DexCom received a warning letter from the Food and Drug Administration following inspections of its San Diego and Mesa, Ariz.
For communications leaders across industries, this initiative underscores the critical importance of crafting clear messaging ...
Dr. Makary argues for more humility from the medical establishment and common sense when reviewing experimental drugs for ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback